Friday, Feb 16, 2024 | 12:00 AM ET

S4 E41: A New Dawn in Early Cancer Detection with Dr. Megan Hall of GRAIL

In this groundbreaking era of healthcare, the opportunity to revolutionize cancer outcomes has never been more promising. With cutting-edge testing techniques, early detection strategies, and the power of AI, the landscape of cancer care is evolving to save lives and enhance patient well-being like never before.

In this episode of HLTH Matters, Dr. Gautam Gulati sits down with Dr. Megan Hall to discuss the future of cancer detection and prevention through early genetic testing. 

Dr. Megan Hall is the Vice President of Corporate Affairs at GRAIL. With a Ph.D. in microbiology, immunology, and molecular genetics she is dedicated to making early cancer detection and prevention accessible on a population scale.

As Dr. Hall says, “I was enamored of the mission to detect cancer early when it can be cured. That's a huge problem that we have to be frank have not made great headway on in the 50 years that we've been waging this war on cancer.” 

Now she shares how GRAIL's flagship product, Galleri, is using advanced technology, including DNA methylation analysis and artificial intelligence (AI), to detect and predict cancer in a non-invasive way. 

Listen in as we explore the potential cost savings and improved outcomes with early cancer detection, and GRAIL's efforts to make this transformative technology accessible to a broader population. 

Topics Covered

  • The significance of early detection in cancer care
  • The role of DNA methylation in cancer detection
  • The importance of evaluating the accuracy of cancer screening and the power of positive predictive value
  • The need for education across the cancer care continuum
  • The potential for healthcare cost savings with early cancer detection
  • The role of AI and machine learning in cancer detection
  • GRAIL's focus on expanding access to cancer screening and its plans for future products

Connect with Dr. Megan Hall

Connect with Dr. Gautam Gulati & Dr. Jessica Shepherd 



Megan Hall, Ph.D.Head of Corporate Affairs, Distinguished Scientist, GRAIL, LLC

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved